×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EKSO – ekso bionics holdings, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EKSO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
07:45 am
ekso
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch’s Groundbreaking BalanceTutor™ Rehabilitation System
High
Report
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch’s Groundbreaking BalanceTutor™ Rehabilitation System
12/2
03:41 pm
ekso
Ekso Bionics (NASDAQ:EKSO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Neutral
Report
Ekso Bionics (NASDAQ:EKSO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/28
06:44 am
ekso
How Recent Moves Are Rewriting the Story for Ekso Bionics [Yahoo! Finance]
Medium
Report
How Recent Moves Are Rewriting the Story for Ekso Bionics [Yahoo! Finance]
11/19
07:00 am
ekso
Ekso Bionics (NASDAQ:EKSO) was given a new $6.00 price target on by analysts at HC Wainwright.
Medium
Report
Ekso Bionics (NASDAQ:EKSO) was given a new $6.00 price target on by analysts at HC Wainwright.
11/18
11:04 am
ekso
Ekso Bionics (NASDAQ:EKSO) had its price target raised by analysts at HC Wainwright from $4.00 to $6.00. They now have a "buy" rating on the stock.
Low
Report
Ekso Bionics (NASDAQ:EKSO) had its price target raised by analysts at HC Wainwright from $4.00 to $6.00. They now have a "buy" rating on the stock.
10/29
08:00 am
ekso
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
Medium
Report
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
10/28
04:05 pm
ekso
Ekso Bionics Reports Third Quarter 2025 Financial Results
Medium
Report
Ekso Bionics Reports Third Quarter 2025 Financial Results
10/24
12:21 pm
ekso
Ekso Bionics (NASDAQ:EKSO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Ekso Bionics (NASDAQ:EKSO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
10/28/2025
04:05 pm
ekso
ekso bionics holdings, inc.
BEAT
Report
9.1%
ekso bionics holdings, inc.
7/28/2025
04:05 pm
ekso
ekso bionics holdings, inc.
MISS
Report
-20.9%
ekso bionics holdings, inc.
5/5/2025
04:05 pm
ekso
ekso bionics holdings, inc.
MISS
Report
-13.0%
ekso bionics holdings, inc.
3/3/2025
04:05 pm
ekso
ekso bionics holdings, inc.
MISS
Report
-1.2%
ekso bionics holdings, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
05:06 pm
ekso
Form 4 EKSO BIONICS HOLDINGS, For: Nov 10 Filed by: Wong Jerome
High
Report
Form 4 EKSO BIONICS HOLDINGS, For: Nov 10 Filed by: Wong Jerome
11/12
05:05 pm
ekso
Form 4 EKSO BIONICS HOLDINGS, For: Nov 10 Filed by: Jones Jason C
High
Report
Form 4 EKSO BIONICS HOLDINGS, For: Nov 10 Filed by: Jones Jason C
11/12
05:04 pm
ekso
Form 4 EKSO BIONICS HOLDINGS, For: Nov 10 Filed by: Davis Scott G.
High
Report
Form 4 EKSO BIONICS HOLDINGS, For: Nov 10 Filed by: Davis Scott G.
11/7
05:49 pm
ekso
Form 4 EKSO BIONICS HOLDINGS, For: Nov 05 Filed by: Davis Scott G.
Medium
Report
Form 4 EKSO BIONICS HOLDINGS, For: Nov 05 Filed by: Davis Scott G.
11/7
05:48 pm
ekso
Form 4 EKSO BIONICS HOLDINGS, For: Nov 05 Filed by: Jones Jason C
Medium
Report
Form 4 EKSO BIONICS HOLDINGS, For: Nov 05 Filed by: Jones Jason C
11/7
05:47 pm
ekso
Form 4 EKSO BIONICS HOLDINGS, For: Nov 05 Filed by: Wong Jerome
Medium
Report
Form 4 EKSO BIONICS HOLDINGS, For: Nov 05 Filed by: Wong Jerome
11/7
05:04 pm
ekso
Form 8-K EKSO BIONICS HOLDINGS, For: Nov 05
Medium
Report
Form 8-K EKSO BIONICS HOLDINGS, For: Nov 05
10/30
06:35 am
ekso
Form 8-K EKSO BIONICS HOLDINGS, For: Oct 28
Medium
Report
Form 8-K EKSO BIONICS HOLDINGS, For: Oct 28
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/9
Ekso Bionics Provides COVID-19 Business Update and Reports Preliminary First Quarter 2020 Financial Results
14.0%
12/27 Form SC 13G EKSO BIONICS HOLDINGS, Filed by: ARMISTICE CAPITAL, LLC 11.8%
3/18 Form 8-K EKSO BIONICS HOLDINGS, For: Mar 12 11.6%
10/28 Ekso Bionics Holdings Inc (NASDAQ: EKSO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 10.8%
8/8 Ekso Bionics Holdings Inc (NASDAQ: EKSO) had its "buy" rating re-affirmed by analysts at Aegis. They now have a $2.90 price target on the stock. 7.8%
4/23 Ekso Bionics® to Report First Quarter 2020 Financial Results on April 30, 2020 7.5%
5/22 Ekso Bionics Announces Pricing of $10 Million Public Offering 6.2%
2/6 Ekso Bionics® Releases its Upgraded EksoPulse Platform, Advanced Cloud-Based Analytics for Robotic Exoskeleton-Assisted Rehabilitation 4.5%
4/24 Form 8-K EKSO BIONICS HOLDINGS, For: Apr 20 4.3%
3/31 Ekso Bionics Holdings Inc (NASDAQ: EKSO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.2%
12/27 Form SC 13G EKSO BIONICS HOLDINGS, Filed by: ARMISTICE CAPITAL, LLC 11.8%
3/18 Form 8-K EKSO BIONICS HOLDINGS, For: Mar 12 11.6%
10/28 Ekso Bionics Holdings Inc (NASDAQ: EKSO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 10.8%
8/8 Ekso Bionics Holdings Inc (NASDAQ: EKSO) had its "buy" rating re-affirmed by analysts at Aegis. They now have a $2.90 price target on the stock. 7.8%
4/23 Ekso Bionics® to Report First Quarter 2020 Financial Results on April 30, 2020 7.5%
5/22 Ekso Bionics Announces Pricing of $10 Million Public Offering 6.2%
2/6 Ekso Bionics® Releases its Upgraded EksoPulse Platform, Advanced Cloud-Based Analytics for Robotic Exoskeleton-Assisted Rehabilitation 4.5%
4/24 Form 8-K EKSO BIONICS HOLDINGS, For: Apr 20 4.3%
3/31 Ekso Bionics Holdings Inc (NASDAQ: EKSO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.2%
TOP News Decliners
5/21
Ekso Bionics Announces Proposed Public Offering of Common Stock and Warrants
-23.9%
8/1 Form 8-K EKSO BIONICS HOLDINGS, For: Aug 01 -23.2%
2/27 Form 8-K EKSO BIONICS HOLDINGS, For: Feb 27 -17.1%
12/19 Ekso Bionics Announces $5.0 Million Registered Direct Offering -16.0%
2/25 Ekso Bionics® Announces Collaboration with Kindred Healthcare to Pilot EksoNR in Long-Term Acute Care Hospitals -12.3%
8/15 Ekso Bionics® Unveils the Next Generation Exoskeleton for Neurorehabilitation -10.9%
1/10 Form 8-K EKSO BIONICS HOLDINGS, For: Jan 10 -10.2%
10/30 Form 8-K EKSO BIONICS HOLDINGS, For: Oct 30 -9.7%
12/20 Form 8-K EKSO BIONICS HOLDINGS, For: Dec 18 -8.6%
4/2 Form 4 EKSO BIONICS HOLDINGS, For: Apr 01 Filed by: Jones Jason C -8.6%
8/1 Form 8-K EKSO BIONICS HOLDINGS, For: Aug 01 -23.2%
2/27 Form 8-K EKSO BIONICS HOLDINGS, For: Feb 27 -17.1%
12/19 Ekso Bionics Announces $5.0 Million Registered Direct Offering -16.0%
2/25 Ekso Bionics® Announces Collaboration with Kindred Healthcare to Pilot EksoNR in Long-Term Acute Care Hospitals -12.3%
8/15 Ekso Bionics® Unveils the Next Generation Exoskeleton for Neurorehabilitation -10.9%
1/10 Form 8-K EKSO BIONICS HOLDINGS, For: Jan 10 -10.2%
10/30 Form 8-K EKSO BIONICS HOLDINGS, For: Oct 30 -9.7%
12/20 Form 8-K EKSO BIONICS HOLDINGS, For: Dec 18 -8.6%
4/2 Form 4 EKSO BIONICS HOLDINGS, For: Apr 01 Filed by: Jones Jason C -8.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: